What is the share price of Phaarmasia Ltd (PHRMASI) today?
The share price of PHRMASI as on 15th July 2025 is ₹35.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Phaarmasia Ltd (PHRMASI) share?
The past returns of Phaarmasia Ltd (PHRMASI) share are- Past 1 week: -9.00%
- Past 1 month: 7.13%
- Past 3 months: 29.82%
- Past 6 months: -21.35%
- Past 1 year: -38.65%
- Past 3 years: 31.25%
- Past 5 years: 92.97%
What are the peers or stocks similar to Phaarmasia Ltd (PHRMASI)?
The peers or stocks similar to Phaarmasia Ltd (PHRMASI) include:What is the market cap of Phaarmasia Ltd (PHRMASI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Phaarmasia Ltd (PHRMASI) is ₹24.43 Cr as of 15th July 2025.What is the 52 week high and low of Phaarmasia Ltd (PHRMASI) share?
The 52-week high of Phaarmasia Ltd (PHRMASI) is ₹64.53 and the 52-week low is ₹23.60.What is the PE and PB ratio of Phaarmasia Ltd (PHRMASI) stock?
The P/E (price-to-earnings) ratio of Phaarmasia Ltd (PHRMASI) is -15.36. The P/B (price-to-book) ratio is 2.37.Which sector does Phaarmasia Ltd (PHRMASI) belong to?
Phaarmasia Ltd (PHRMASI) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Phaarmasia Ltd (PHRMASI) shares?
You can directly buy Phaarmasia Ltd (PHRMASI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Phaarmasia Ltd
PHRMASI Share Price
35.700.22% (-0.08)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PHRMASI Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
PHRMASI Performance & Key Metrics
PHRMASI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -15.27 | 2.37 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.43 | 6.45 | 0.81% |
PHRMASI Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
PHRMASI Company Profile
Phaarmasia Limited manufactures and markets oral contraceptive pills and other hormone products, serving both domestic and export markets.
SUNPHARMA
PE Ratio
36.94
36.94
1Y Return
8.91%
8.91%
Buy Reco %
84.85
84.85
CIPLA
PE Ratio
22.73
22.73
1Y Return
1.73%
1.73%
Buy Reco %
68.75
68.75
TORNTPHARM
PE Ratio
60.29
60.29
1Y Return
16.45%
16.45%
Buy Reco %
70.83
70.83
MANKIND
PE Ratio
55.89
55.89
1Y Return
23.38%
23.38%
Buy Reco %
81.25
81.25
DRREDDY
PE Ratio
18.40
18.40
1Y Return
7.22%
7.22%
Buy Reco %
48.39
48.39
PHRMASI Forecast
PHRMASI Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
PHRMASI
PHRMASI
Income
Balance Sheet
Cash Flow
Annual Normal View
PHRMASI Income Statement
PHRMASI Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14.94 | 19.50 | 24.79 | 20.51 | 17.15 | 17.69 | 28.01 | 31.25 | 25.12 | 25.11 | ||||||||||
Raw Materials | 6.73 | 11.05 | 17.88 | 18.35 | 12.49 | 14.35 | 24.13 | 24.01 | 26.38 | 26.39 | ||||||||||
| Power & Fuel Cost | 0.98 | 1.20 | 0.98 | 0.90 | 0.58 | 0.53 | 0.73 | 0.77 | ||||||||||||
| Employee Cost | 1.42 | 1.66 | 1.55 | 1.40 | 1.36 | 1.17 | 1.41 | 1.53 | ||||||||||||
| Selling & Administrative Expenses | 2.28 | 0.91 | 2.68 | -3.08 | -2.49 | 1.43 | 1.71 | 1.66 | ||||||||||||
| Operating & Other expenses | 2.81 | 3.49 | 0.38 | 1.55 | 4.38 | 1.47 | 1.06 | 3.45 | ||||||||||||
EBITDA | 0.72 | 1.19 | 1.32 | 1.39 | 0.83 | -1.26 | -1.03 | -0.17 | -1.26 | -1.28 | ||||||||||
| Depreciation/Amortization | 0.44 | 0.47 | 0.46 | 0.40 | 0.34 | 0.29 | 0.36 | 0.34 | 0.32 | 0.32 | ||||||||||
| PBIT | 0.28 | 0.72 | 0.86 | 0.99 | 0.49 | -1.55 | -1.39 | -0.51 | -1.58 | -1.60 | ||||||||||
| Interest & Other Items | 0.01 | 0.04 | 0.04 | 0.04 | 0.01 | 0.00 | 0.04 | 0.04 | 0.02 | 0.01 | ||||||||||
| PBT | 0.27 | 0.68 | 0.82 | 0.95 | 0.48 | -1.55 | -1.43 | -0.55 | -1.60 | -1.61 | ||||||||||
| Taxes & Other Items | 0.10 | 0.11 | 0.05 | 0.43 | 0.16 | -0.02 | -0.17 | -0.03 | -0.01 | -0.01 | ||||||||||
| Net Income | 0.17 | 0.57 | 0.77 | 0.52 | 0.32 | -1.53 | -1.26 | -0.52 | -1.59 | -1.60 | ||||||||||
| EPS | 0.25 | 0.83 | 1.13 | 0.76 | 0.47 | -2.24 | -1.85 | -0.76 | -2.33 | -2.34 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PHRMASI Company Updates
PHRMASI Stock Peers
PHRMASI Past Performance & Peer Comparison
PHRMASI Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Phaarmasia Ltd | -15.36 | 2.37 | — |
| Sun Pharmaceutical Industries Ltd | 36.94 | 5.57 | 0.95% |
| Cipla Ltd | 22.73 | 3.83 | 1.08% |
| Torrent Pharmaceuticals Ltd | 60.29 | 15.18 | 0.94% |
PHRMASI Stock Price Comparison
Compare PHRMASI with any stock or ETFCompare PHRMASI with any stock or ETF
PHRMASI
PHRMASI Holdings
PHRMASI Shareholdings
PHRMASI Promoter Holdings Trend
PHRMASI Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
PHRMASI Institutional Holdings Trend
PHRMASI Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
PHRMASI Shareholding Pattern
PHRMASI Shareholding Pattern
PHRMASI Shareholding History
PHRMASI Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing PHRMASI stock
smallcases containing PHRMASI stock
Looks like this stock is not in any smallcase yet.
PHRMASI Events
PHRMASI Events
PHRMASI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PHRMASI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PHRMASI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PHRMASI has not given any dividends in last 5 years
PHRMASI Dividends
PHRMASI Dividends
Hmm, looks like data is unavailable here. Please come back after some timePHRMASI Stock News & Opinions
PHRMASI Stock News & Opinions
Articles & Videos
Earnings
Phaarmasia reports standalone net loss of Rs 0.53 crore in the March 2025 quarter
Net loss of Phaarmasia reported to Rs 0.53 crore in the quarter ended March 2025 as against net profit of Rs 0.47 crore during the previous quarter ended March 2024. Sales declined 45.65% to Rs 5.43 crore in the quarter ended March 2025 as against Rs 9.99 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 1.59 crore in the year ended March 2025 as against net loss of Rs 0.52 crore during the previous year ended March 2024. Sales declined 20.33% to Rs 24.37 crore in the year ended March 2025 as against Rs 30.59 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales5.439.99 -46 24.3730.59 -20 OPM %-11.423.30 --8.25-2.71 - PBDT-0.440.52 PL -1.28-0.21 -510 PBT-0.520.43 PL -1.60-0.55 -191 NP-0.530.47 PL -1.59-0.52 -206 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Phaarmasia to convene board meeting
Phaarmasia will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Phaarmasia reports standalone net loss of Rs 0.70 crore in the December 2024 quarter
Net Loss of Phaarmasia reported to Rs 0.70 crore in the quarter ended December 2024 as against net loss of Rs 0.56 crore during the previous quarter ended December 2023. Sales declined 7.09% to Rs 4.72 crore in the quarter ended December 2024 as against Rs 5.08 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales4.725.08 -7 OPM %-16.74-11.22 - PBDT-0.61-0.46 -33 PBT-0.69-0.54 -28 NP-0.70-0.56 -25 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Phaarmasia to hold board meeting
Phaarmasia will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Phaarmasia reports standalone net loss of Rs 0.64 crore in the September 2024 quarter
Net Loss of Phaarmasia reported to Rs 0.64 crore in the quarter ended September 2024 as against net loss of Rs 0.16 crore during the previous quarter ended September 2023. Sales declined 31.37% to Rs 5.93 crore in the quarter ended September 2024 as against Rs 8.64 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.938.64 -31 OPM %-13.15-3.13 - PBDT-0.56-0.08 -600 PBT-0.64-0.17 -276 NP-0.64-0.16 -300 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Phaarmasia to hold board meeting
Phaarmasia will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Phaarmasia reports standalone net profit of Rs 0.28 crore in the June 2024 quarter
Net profit of Phaarmasia reported to Rs 0.28 crore in the quarter ended June 2024 as against net loss of Rs 0.27 crore during the previous quarter ended June 2023. Sales rose 20.49% to Rs 8.29 crore in the quarter ended June 2024 as against Rs 6.88 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales8.296.88 20 OPM %2.17-4.51 - PBDT0.33-0.18 LP PBT0.25-0.27 LP NP0.28-0.27 LP Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Phaarmasia to discuss results
Phaarmasia will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 4.14%, vs industry avg of 10.15%
Over the last 5 years, market share stayed at 0.01%